AUSTIN, Texas, March 11, 2025 — OsteoCentric Technologies, a global leader in pioneering medical technologies, has announced a non-exclusive licensing agreement with Globus Medical, Inc., a prominent provider of solutions for musculoskeletal conditions.

OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form, which has been proven effective in clinical settings, represents the first implant-to-bone connection capable of maintaining initial implant stability over time. OsteoCentric aims to revolutionize the orthopaedic field by moving beyond conventional interfaces that can harm bone during implant placement.

OsteoCentric Technologies is promoting the extensive use of its innovative interface technology across all areas of the orthopaedic market, including, but not limited to, total joint reconstruction, trauma, spine, SI joint fusion, sports medicine, extremities, veterinary, oncology, bone-anchored prostheses, and dental applications.

For further details on OsteoCentric Technologies, please visit .

Discover more about OsteoCentric at the American Academy of Orthopaedic Surgeons Annual 2025 Meeting. Booth #1739.

About OsteoCentric Technologies

OsteoCentric Technologies is spearheading a global, industry-wide transformation by creating novel solutions to tackle the widespread problem of bone damage and compromised implant stability. The company’s objective is to enhance orthopaedic medical technologies and patient outcomes by providing superior, long-lasting biomechanical implant stability that improves and speeds up the patient’s recovery process.

SOURCE OsteoCentric Technologies

“`